Literature DB >> 32839146

Antiretroviral therapy in community pharmacies - Implementation and outcomes of a differentiated drug delivery model in Nigeria.

Iyeseun O Asieba1, Dorothy A Oqua2, Anthony A Wutoh3, Kenneth A Agu2, Onuche I Omeh2, Zainab A Adeyanju2, Afusat Adesina2, Festus Agu2, Peter Agada2, Anthony Achanya2, Nnenna Ekechuwu2, Toyin Tofade3.   

Abstract

INTRODUCTION: The World Health Organization recommended differentiated models of care portends opportunities to decongest hospitals providing antiretroviral therapy (ART) and improve retention, especially in developing countries. A community pharmacy-based ART refill model was implemented where stable clients were devolved to community pharmacies for routine refills at a service fee, to promote private sector participation and sustainability of ART services. The aim of this study was to assess the feasibility, acceptability and outcomes of this model in Nigeria.
METHODS: A population-based retrospective analysis of the community pharmacy ART refill program of the United States Agency for International Development-funded 'Strengthening Integrated Delivery of HIV/AIDS Services' project in Lagos, Rivers, Cross River and Akwa Ibom States from October 2016 to February 2018 was conducted. Standard descriptive statistical methods were used for baseline demographic and clinical characteristics of study participants. Outcomes were assessed using the Chi-square test and a multivariate logistic regressions model. Statistical significance was defined at α-level of 0.05. Analyses were performed using SPSS for Windows version 23 (IBM Corp, Armonk, USA).
RESULTS: A total of 10015 participants representing 14.4% of ART clients in 50 hospitals opted for this model and were devolved to 244 community pharmacies. All clients consented and paid a service fee of N1000 (about $3) per refill visit. Median follow-up duration was 6 months. Prescription refill rate was 95% (95% CI 94.2-95.3). Retention rate was 98% while viral suppression was 99.12%. Refill rates were significantly affected by ART duration, regimen, age and location (P < 0.001, 0.004, 0.034 and < 0.001 respectively).
CONCLUSIONS: This community pharmacy ART refill model of differentiated care is feasible and acceptable by clients and providers and demonstrated excellent clinical outcomes of retention and viral suppression. The ability and willingness of some clients to contribute financially to their HIV care was also demonstrated.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiretroviral therapy; Community pharmacy; Differentiated care; Fee for service; Retention; Viral suppression

Year:  2020        PMID: 32839146     DOI: 10.1016/j.sapharm.2020.06.025

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  3 in total

1.  Impact of the COVID-19 pandemic: Community and hospital shared pharmaceutical care model. Satisfaction and acceptability of patients with HIV infection on antiretroviral treatment.

Authors:  M E Molas; H Knobel; O Ferrández; M de Antonio Cuscó; N Carballo Martínez; C Rodríguez Caba; S Luque; A Guelar; S Castañeda Espinosa; S Grau
Journal:  Rev Esp Quimioter       Date:  2021-11-26       Impact factor: 1.553

2.  Interventions to improve early retention of patients in antiretroviral therapy programmes in sub-Saharan Africa: A systematic review.

Authors:  Samuel Muhula; John Gachohi; Yeri Kombe; Simon Karanja
Journal:  PLoS One       Date:  2022-02-09       Impact factor: 3.240

3.  Provider- and patient-level costs associated with providing antiretroviral therapy during the postpartum phase to women living with HIV in South Africa: A cost comparison of three postpartum models of care.

Authors:  Lucy Cunnama; Elaine J Abrams; Landon Myer; Tamsin K Phillips; Caitlin M Dugdale; Andrea L Ciaranello; Allison Zerbe; Victoria Iyun; Kim MacQuilkan; Vanessa Daries; Edina Sinanovic
Journal:  Trop Med Int Health       Date:  2020-10-02       Impact factor: 2.622

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.